Compare MBOT & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBOT | RMMZ |
|---|---|---|
| Founded | 2010 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.3M | 123.9M |
| IPO Year | N/A | N/A |
| Metric | MBOT | RMMZ |
|---|---|---|
| Price | $2.15 | $14.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 25.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,119.61 | N/A |
| P/E Ratio | ★ N/A | $19.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.25 | $12.92 |
| 52 Week High | $4.67 | $16.99 |
| Indicator | MBOT | RMMZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.61 | 43.31 |
| Support Level | $1.95 | $14.65 |
| Resistance Level | $2.14 | $14.83 |
| Average True Range (ATR) | 0.11 | 0.23 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 51.39 | 26.51 |
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.